A recent study suggests that people who discontinue popular weight-loss injections like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end conventional diet and exercise plans.
Published data in a leading health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these treatments need to be informed of the risk of rapid rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a return to original weight in about 18 months.
Comparing Therapies
The study, which looked at 37 of studies involving over 9,000 of patients, compared the effects of these new drugs with other pills.
The team emphasize that individuals who shed pounds through dieting usually experience a more gradual creep back—around 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Doctors suggest the way of the drugs explains the amplified rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication means hunger is no longer kept in check, making excessive eating much more probable."
An Ongoing Issue?
Medical guidelines advise the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals argue that, due to the likelihood of relapse, the treatment should be considered long-term.
This opinion is supported by pharmaceutical companies, who note that the findings "underscore the persistent character of obesity," akin to managing conditions like diabetes.
Patient Experiences
People who have stopped the medication describe a sudden return of appetite.
"I experienced a switch activating and you're instantly extremely hungry," recalled one woman.
The struggle is compounded if patients have not adopted permanent dietary or behavioural changes during therapy.
Significant Use
Recent estimates show that a significant number of adults in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is higher among women than men.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
Ultimately, researchers stress that while these medications are effective agents for weight loss, they are not a magic fix and long-term success likely depends on combined behavioural management.